Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Risk Factors for Breakthrough Candidemia
Authors
M. Nucci
A. Colombo
Publication date
01-03-2002
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2002
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-002-0697-1

Other articles of this Issue 3/2002

European Journal of Clinical Microbiology & Infectious Diseases 3/2002 Go to the issue

Article

Differences Between National Reference Laboratories of the European Community in Their Ability to Serotype Salmonella Species

Announcement

Announcements

Article

Comparison of Porphyrin-Based, Growth Factor-Based, and Biochemical-Based Testing Methods for Identification of Haemophilus influenzae

Concise Article

Usefulness of PCR for Diagnosis of Imported Malaria in Poland

Brief Report

Brain Abscess due to Capnocytophaga Species, Actinomyces Species, and Streptococcus intermedius in a Patient with Cyanotic Congenital Heart Disease

Concise Article

Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii Meningitis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits